INNV icon

InnovAge Holding

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 46.7%
Negative

Positive
Zacks Investment Research
12 days ago
Take the Zacks Approach to Beat the Markets: Stride, InnovAge, PepsiCo in Focus
LRN's surge, INNV's upgrade-driven rally and PEP's steady gains showcase how Zacks strategies are outperforming despite ongoing market volatility.
Take the Zacks Approach to Beat the Markets: Stride, InnovAge, PepsiCo in Focus
Positive
Zacks Investment Research
1 month ago
New Strong Buy Stocks for March 18th
NWPX, INNV, WGS, BCBP and BWXT have been added to the Zacks Rank #1 (Strong Buy) List on March 18, 2026.
New Strong Buy Stocks for March 18th
Neutral
Zacks Investment Research
1 month ago
3 Medical Service Industry Stocks Set to Counter Workforce Issues
BTSG, INNV and PACS could benefit as the medical services industry embraces digital health and analytics, though workforce shortages still pressure providers.
3 Medical Service Industry Stocks Set to Counter Workforce Issues
Positive
Zacks Investment Research
1 month ago
All You Need to Know About InnovAge (INNV) Rating Upgrade to Strong Buy
InnovAge (INNV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
All You Need to Know About InnovAge (INNV) Rating Upgrade to Strong Buy
Positive
Zacks Investment Research
1 month ago
InnovAge (INNV) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
InnovAge (INNV) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
InnovAge (INNV) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Positive
Zacks Investment Research
1 month ago
New Strong Buy Stocks for March 6th
TFPM, NEM, INNV, MGA and HAYW have been added to the Zacks Rank #1 (Strong Buy) List on March 6, 2026.
New Strong Buy Stocks for March 6th
Positive
Zacks Investment Research
1 month ago
Earnings Estimates Moving Higher for InnovAge (INNV): Time to Buy?
InnovAge Holding Corp. (INNV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Earnings Estimates Moving Higher for InnovAge (INNV): Time to Buy?
Neutral
Seeking Alpha
1 month ago
InnovAge: The Headwinds Are Priced In, The Growth May Not Be
InnovAge Holding Corp. delivers strong operational execution, driving significant revenue and margin expansion through its PACE model for elderly care. INNV's revenue rose 14.7% year-over-year, fueled by participant growth and capitation rate adjustments across established centers. Disciplined cost management and SG&A reductions have expanded center-level contribution margin to 22% and adjusted EBITDA margin to 9.2%.
InnovAge: The Headwinds Are Priced In, The Growth May Not Be
Positive
Zacks Investment Research
2 months ago
InnovAge (INNV) Upgraded to Strong Buy: What Does It Mean for the Stock?
InnovAge (INNV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
InnovAge (INNV) Upgraded to Strong Buy: What Does It Mean for the Stock?
Neutral
GlobeNewsWire
2 months ago
Proven Senior Care Model Takes Center Stage at the Capitol
DENVER, Feb. 05, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), a leading Program of All-Inclusive Care for the Elderly (PACE) provider, in partnership with LeadingAge Colorado, met with state lawmakers today at the Colorado State Capitol to underscore the importance of protecting and strengthening care for Colorado's aging population, including through PACE. Seniors enrolled in InnovAge Colorado PACE met with several lawmakers to share firsthand how the program delivers comprehensive, person-centered care that allows older adults to remain living safely and independently in their homes and communities.
Proven Senior Care Model Takes Center Stage at the Capitol